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Effects of intermittent theta burst stimulation on spasticity
after stroke
Dae Hyun Kima, Ji Cheol Shinb, Seungsoo Jungc, Tae-Min Jungb
and Deog Young Kimb
Spasticity is a common cause of long-term disability in
poststroke hemiplegic patients. We investigated whether
intermittent theta burst stimulation (iTBS) could reduce
upper-limb spasticity after a stroke. Fifteen hemiplegic
stroke patients were recruited for a double-blind sham-
controlled cross-over design study. A single session of iTBS
or sham stimulation was delivered on the motor hotspot of
the affected flexor carpi radialis muscle in a random and
counterbalanced order with a 1-week interval. Modified
Ashworth scale (MAS), modified Tardieu scale (MTS),
H-wave/M-wave amplitude ratio, peak torque (PT), peak
torque angle (PTA), work of affected wrist flexor, and
rectified integrated electromyographic activity of the flexor
carpi radialis muscle were measured before, immediately
after, 30min after, and 1 week after iTBS or sham
stimulation. Repeated-measures analysis of variance
showed a significant interaction between time and
intervention for the MAS, MTS, PT, PTA, and rectified
integrated electromyographic activity (P< 0.05), indicating
that these parameters were significantly improved by iTBS
compared with sham stimulation. However, the
H-wave/M-wave amplitude ratio and work were not
affected. MAS and MTS significantly improved for at least
30min after iTBS, but the other parameters only improved
immediately after iTBS (P< 0.05). In conclusion, iTBS on the
affected hemisphere may help to reduce poststroke
spasticity transiently. NeuroReport 26:561–566 Copyright ©
2015 Wolters Kluwer Health, Inc. All rights reserved.
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Introduction
Spasticity is a common disorder, with a prevalence of
about 35% in stroke patients [1], and it increases func-
tional impairment and significantly impacts activities and
quality of daily life [2]. Although many therapies are
available, none is universally effective.
Spasticity can be defined as a velocity-dependent
increase in muscle tone, and its pathophysiology is
commonly believed to involve lesions of upper motor
neurons, which modulate the activity of the spinal circuit
[2]. Thus, reduced inhibitory upper motor neuron activ-
ity may lead to overactivation of α and γ motor neurons
and a large group of interneurons at the spinal level [1].
Therefore, techniques that modulate the excitability of
upper motor neurons (e.g. transcranial magnetic stimu-
lation) may be a treatment option for spasticity.
Repetitive transcranial magnetic stimulation (rTMS) can
noninvasively alter the cortical excitability at the site of sti-
mulation [3]. Some previous studies showed that conven-
tional rTMS can reduce the spasticity, as measured by a
modified Ashworth scale (MAS) [4–6] and the F-wave/M-
wave amplitude ratio [7,8]. However, these studies were
limited to clinical and/or electrophysiological measurements.
Moreover, theta burst stimulation (TBS), a novel rTMS
stimulation protocol that requires less stimulation time than
conventional rTMS, has not been attempted.
Thus, our aim was to determine whether intermittent
TBS (iTBS) may significantly reduce upper-limb spasti-
city after a stroke on the basis of clinical, electro-
physiological, and biomechanical assessments.
Methods
Participants
Fifteen stroke patients (10 women, five men) who ful-
filled the following criteria were recruited: (a) a first ever
unilateral stroke, as confirmed by MRI or computed
tomography; (b) supratentorial stroke; (c) at least 18 years
of age; (d) wrist flexor spasticity with a MAS score of 2 or
less; (e) suspended antispastic medications and/or phy-
siotherapy at least 1 month ago; and (f) cognitive function
sufficient to allow cooperation. Exclusion criteria were as
follows: (a) seizure history or ictal wave form on the
electroencephalogram; (b) contraindications for rTMS [9]
(e.g. intracranial implants, cardiac pacemakers, or preg-
nancy, implanted medication pumps); or (c) coexisting
neurological and orthopedic disease. The age of the
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patients was 60.7 ± 8.7 years (range= 40–92 years) and
the duration since the stroke was 8.7 ± 13.6 months.
The patients’ characteristics are summarized in Table 1.
The group size was comparable with that of other studies
of rTMS and spasticity [2,8]. The study was approved by
our Institutional Research Ethics Committee for Human
Subjects. Informed consent was obtained from all
patients before the study.
Experimental design
This study used a double-blind, sham-controlled, cross-
over design. Each patient underwent two different sti-
mulations of the affected hemisphere: iTBS and sham.
The order of these stimulations was randomized and
counterbalanced for all patients. The iTBS and sham
stimulation sessions were separated by a 1-week interval
to minimize carryover effects.
To familiarize patients with the outcome measurements,
the same procedures were performed more than five times
to obtain stable data on the day before the stimulation
session; data of last trials were obtained (T− 1). The out-
come measurements were evaluated by an experienced
physiatrist before (T0), immediately after (T1), 30min
after (T2), and 1 week after stimulation (T3). We could not
find a significant difference in any of the outcome mea-
surements between on the day before the stimulation
(T− 1) and before stimulation on the experimental day
(T0). The outcome measurements were completed within
10min after the stimulation session. The physician who
performed the stimulation was instructed not to disclose
the stimulation order to the patients and another physician
who assessed the parameters.
Intermittent theta burst stimulation
iTBS was administered using a Magstim Rapid magnetic
stimulator (Magstim Company, Whitland, UK) connected
to a figure-of-eight coil (diameter= 70 mm). It was
delivered over the motor hotspot of the affected flexor
carpi radialis muscle (FCR). The stimulation intensity
was 80% of the active motor threshold [10]. The iTBS
protocol consisted of 10 bursts, each of which was com-
posed of three stimuli at 50 Hz, repeated at a theta fre-
quency of 5 Hz every 10 s for a total of 600 stimuli (200 s)
[10]. If no motor-evoked potential (MEP) was detectable
from the FCR of the affected limb, the stimulation
location was established as the equivalent point of the
scalp in the affected hemisphere relative to the unaf-
fected motor hot spot of the FCR. In these cases, the
stimulation intensity was set to 50% of the maximum
stimulator output [2]. For the sham stimulation, iTBS
was delivered (80% of the active motor threshold) with
the coil held close over the motor area corresponding to
the affected limb as determined for iTBS, but tilted ∼ 90°
so that no current was induced in the brain [2]. The sti-
mulation intensity was 48.1 ± 2.7 of the maximum sti-
mulator output. The MEP from the FCR in the affected
limb were detected in six patients (Table 1).
Outcome measurements
The wrist flexor spasticity was assessed systematically by
clinical, electrophysiological, and biomechanical mea-
surements. Clinical assessments were performed using
MAS and the modified Tardieu scale (MTS). MAS was
scored using a six-point (0, 1, 1.5, 2, 3, 4) scale [4]
and MTS involving scoring of R1 and R2 was also
assessed [11]. Electrophysiological measurements were
obtained using a Synergy system EMG unit (VIASYS
HealthCare Inc., Old Woking, UK) with a bandpass filter
at 20 Hz to 2 kHz, sweep speed at 5 ms/division, and
sensitivity at 200–500 μV. Compound muscle action
potentials, Hoffmann (H) reflex, and electromyographic
(EMG) activity were recorded using Ag–AgCl surface
electrodes on affected FCR. Compound muscle action
potentials and H reflex were evoked 10 times by elec-
trical stimulation of the median nerve through a bipolar
electrode placed in the antecubital fossa (1 ms duration,
20–40mA intensity when set at the minimal M wave)
[12]. The H-wave/M-wave amplitude ratio (H/M ratio)
was calculated and averaged across 10 occurrences.
Biomechanical measurements including the rectified
Table 1 General characteristics of the participants
Patient Sex Age Duration of condition (months) Type of stroke Affected side MAS of wrist flexor MEP Sequence
1 Male 72 11.0 Hemorrhage Left 2 Unaffected side iTBS-sham
2 Female 89 10.2 Ischemic Right 2 Unaffected side iTBS-sham
3 Female 67 10.8 Ischemic Left 1 Unaffected side Sham-iTBS
4 Female 65 2.1 Hemorrhage Right 1 Unaffected side iTBS-sham
5 Male 65 1.5 Ischemic Right 1 Affected side Sham-iTBS
6 Female 54 0.6 Ischemic Left 1 Unaffected side Sham-iTBS
7 Female 43 2.6 Ischemic Left 1+ Affected side iTBS-sham
8 Male 49 36.3 Hemorrhage Right 1 Affected side iTBS-sham
9 Male 49 1.4 Ischemic Right 1 Unaffected side Sham-iTBS
10 Female 65 0.5 Ischemic Left 1 Affected side Sham-iTBS
11 Female 40 3.4 Ischemic Left 1+ Unaffected side Sham-iTBS
12 Female 92 1.5 Ischemic Right 1 Affected side Sham-iTBS
13 Female 71 1.4 Ischemic Right 1+ Unaffected side iTBS-sham
14 Male 48 44.9 Ischemic Left 2 Unaffected side Sham-iTBS
15 Female 41 2.7 Ischemic Right 1 Affected side iTBS-sham
iTBS, intermittent theta burst stimulation; MAS, modified Ashworth scale; MEP, motor-evoked potential.
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integrated EMG activity were performed using an
isokinetic dynamometer (Lumex Inc., Ronkonkoma,
New York, USA) and an MP100 system (BIOPAC Inc.,
Goleta, California, USA). To assess these measurements,
10 continuous passive wrist movements from 45° flexion
to 35° extension were completed at a velocity of 30°/s.
Peak torque (PT) was measured on the basis of the
resistance force applied to the lever during the passive
motion of the wrist. PT (Nm), peak torque angle (PTA)
(°), work (J), and EMG activity (mV) of FCR were
measured simultaneously. The raw data for the EMG
activity were integrated after being rectified using the
Acknowledgement 4.2 program (BIOPAC Inc.).
Statistical analysis
Data analysis was completed using SPSS, version 19.0
(SPSS Inc., Chicago, Illinois, USA). Repeated-measures
analysis of variance (RM-ANOVA) was used to evaluate
the effects of time (T0–T3) and intervention (iTBS and
sham) on spasticity because each patient underwent two
stimulation conditions (iTBS and sham stimulation) and
evaluations were performed at four time points (from T0
to T3). The Wilks’ λ correction was used to correct for
violations of sphericity. When significant differences
were found, post-hoc testing was performed and cor-
rected for multiple comparisons (Bonferroni). For com-
parisons with baseline, an independent t-test was used for
the baseline data of iTBS and sham stimulation. A paired
t-test was used for all parameters between T− 1 and T0
to confirm familiarization. The level for statistical sig-
nificance was set at P value less than 0.05. All data are
expressed as the mean ± SE (Table 2).
Results
Clinical measurements
MAS and MTS at baseline did not differ significantly
between iTBS and sham stimulation. RM-ANOVA
showed a significant interaction between time (T0–T3)
and intervention (iTBS/sham) with respect to MAS
(F= 11.752, P< 0.001) and R1 of MTS (F= 13.365,
P< 0.001), indicating the significant improvements on
MAS and R1 of MTS after iTBS in comparison with the
sham stimulation. However, R2 of MTS did not show any
improvement. On comparison with T0, post-hoc com-
parisons showed that MAS was improved significantly
immediately after (T1) and 30 min after iTBS (T2), but
was not improved at 1 week after stimulation (T3), and
R1 of MTS was also improved significantly immediately
after (T1) and 30 min after both iTBS and sham stimu-
lation (T2) (P< 0.001 with Bonferroni correction), but
was not improved at 1 week after stimulation (T3)
(Table 2 and Fig. 1).
Electrophysiological measurements
The H/M ratio at baseline did not differ significantly
between iTBS and sham stimulation. RM-ANOVA did
not indicate a significant interaction between time
(T0–T3) and intervention (iTBS/sham) on the H/M ratio
(F= 0.405, P= 0.751) (Table 2 and Fig. 2).
Biomechanical measurements
No significant difference in PT, PTA, work, and rectified
integrated EMG activity at baseline could be found
between iTBS and sham stimulation. RM-ANOVA
showed a significant interaction between time (T0–T3)
and intervention (iTBS/sham) with respect to PT
(F= 3.798, P= 0.022), PTA (F= 3.137, P= 0.042), and
rectified integrated EMG activity (F= 8.078, P= 0.001),
indicating that these parameters were significantly
improved after iTBS compared with sham stimulation.
However, work was not improved. On comparison with
T1, post-hoc comparisons showed that PT, PTA, and
rectified integrated EMG activity were improved
immediately after iTBS (T1) (P< 0.001 with Bonferroni
correction), but were not improved at 30 min after (T2) or
1 week after (T3) stimulation (Table 2 and Fig. 3).
Table 2 Changes in clinical, electrophysiological, and biomechanical measures of spasticity after stimulation
Intermittent theta burst stimulation Sham stimulation
Variables T0 T1 T2 T3 T0 T1 T2 T3
Clinical measure
MAS* 1.30 ±0.11 0.47 ±0.13† 0.66 ±0.14† 1.23 ±0.14 1.23 ±0.10 1.17 ±0.13 1.10 ± 0.10 1.23 ±0.10
MTS
R1 (deg.)* 52.00 ±2.33 66.00 ±1.31† 60.00 ±2.34† 52.66 ±3.04 53.00 ±2.38 56.00 ±2.25† 60.00 ± 1.89† 54.00 ±2.02
R2 (deg.) 70.00 ±0.00 70.00 ±0.00 70.00 ±0.00 70.00 ±0.00 70.00 ±0.00 70.00 ±0.00 70.00 ± 0.00 70.00 ±0.00
Electrophysiological measure
H/M amplitude ratio 0.55 ±0.14 0.54 ±0.24 0.56 ±0.18 0.63 ±0.21 0.42 ±0.10 0.44 ±0.11 0.41 ± 0.10 0.44 ±0.11
Biomechanical measure
Peak torque (Nm)* 2.91 ±0.48 2.63 ±0.48† 2.82 ±0.47 2.87 ±0.47 2.89 ±0.47 2.78 ±0.47 2.78 ± 0.48 2.81 ±0.50
Work (J) 1.97 ±0.46 1.89 ±0.48 1.97 ±0.46 1.59 ±0.34 1.63 ±0.33 1.66 ±0.35 1.75 ± 0.37 2.07 ±0.44
Peak torque angle (deg.)* 4.27 ±2.21 9.13 ±1.87† 7.40 ±1.96 3.67 ±2.22 5.13 ±2.05 6.80 ±1.72 6.33 ± 2.17 4.93 ±2.06
EMG (mV/s×10−4)* 2.40 ±0.34 1.44 ±0.16† 2.07 ±0.31 2.00 ±0.38 1.86 ±0.33 1.99 ±0.36 2.02 ± 0.43 2.01 ±0.38
Values are represented as mean ±SE.
EMG, rectified integrated electromyographic activity; H/M, H-wave/M-wave; MAS, modified Ashworth scale; MTS, modified Tardieu scale.
T0, before stimulation; T1, immediately after stimulation; T2, 30 min after stimulation; T3, 1 week after stimulation.
*P<0.05 significant time× intervention factor interaction.
†P<0.05 versus the baseline (T0) within intervention.
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Discussion
This study showed that a single session of iTBS over the
affected motor cortex caused a transient reduction in spas-
ticity after a stroke. These results are consistent with pre-
vious studies reporting a significant reduction of upper-limb
spasticity after conventional rTMS in patients after a stroke
[4,7,8]. However, all previous studies were open-labeled
studies such that the researchers and participants all knew
which stimulation was being administered, or the outcome
measurements in these studies were limited to clinical or
electrophysiological measures. Many measurements of
spasticity were introduced by researchers. These measure-
ments could be classified into clinical, electrophysiological,
and biomechanical measures. Among these, biomechanical
measurements may offer better quantification of spasticity
compared with clinical and electrophysiological measure-
ments [12,13] because clinical measures are highly depen-
dent on the examiner’s judgment [14] and because
electrophysiological measures have high variability and low
reliability [15]. This is the first randomized sham-controlled
study to quantitatively assess the effect of rTMS on spasti-
city using biomechanical measurements.
A significant improvement was found in clinical and
biomechanical assessments after iTBS. However, we failed
to observe a reduction of spasticity as assessed by
electrophysiological measurement. The lack of electro-
physiological changes may be attributed to several factors.
First, the H reflex has high variability and low reliability for
measuring spasticity [12,15]. Second, the stimulation
intensity during active iTBS (80% active motor threshold
of FCR or 50% of maximal stimulation output) was lower
than the intensity to induce electrophysiological changes in
the studies with conventional rTMS, which showed posi-
tive effects on spasticity. Huang et al. [10] also reported
similar findings with TBS that continuous TBS had no
effect on H reflexes evoked in FCR, whereas MEPs were
suppressed in normal individuals. Third, the interneurons
at the spinal level, which are not directly involved in the H
reflex, may play a much larger role in spasticity reduction
after iTBS [3]. Fourth, the symptoms related to the spas-
ticity were similar irrespective of underlying diseases, but
different mechanisms in spasticity may occur depending on
the specific underlying disease of the central nervous sys-
tem [3]. A reduction in the H/M ratio has been reported
following iTBS stimulation of the motor cortex in multiple
sclerosis patients [2], but no changes in the H/M ratio were
reported in patients with spinal-cord injury [3].
We also found that the reduction in spasticity lasted less
than 30 min after a single session of iTBS. These results
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were in line with the studies measuring the upper-limb
motor performance after iTBS in patients after a stroke
[16,17]. Talelli et al. [16] reported that a single session of
iTBS reduced the reaction time by up to 30min, but
changes in MEP size had a duration of ∼ 0 min. Huang
et al. [18] also observed the transient changes in MEP size
for 20 min after iTBS [18]. These results support the use
of iTBS in future longer-term trials for the modulation of
spasticity after a stroke.
The mechanism underlying the anti-spastic effect of
iTBS remains to be determined. iTBS is well-known to
modulate cortical excitability [10], and the increased
neural activity of the corticospinal tract after iTBS may
project to local inhibitory interneurons of the spinal cord.
The corticospinal tract has widespread terminations in
the spinal gray matter, thereby controlling motor neurons
through monosynaptic but also polysynaptic connections
involving local interneurons and sensory afferents [19].
iTBS may also result in changes in the levels of endo-
genous neurotransmitters such as γ-aminobutyric acid,
glutamate, and dopamine, which are all involved in
synaptic plasticity [19]. Although the mechanisms
underlying the effect of iTBS are not yet completely
understood, it is increasingly accepted that they could be
analogous to long-term potentiation plastic changes
recorded in neurons of animal models. Further studies
are needed to explore this issue.
Conclusion
iTBS may be useful to reduce spasticity transiently in
post-stroke patients. The potential clinical relevance is
unclear, but TBS with a shorter stimulation time relative
to conventional rTMS may offer a clinical advantage in
the treatment of spasticity. Finally, further studies are
necessary to explore the underlying mechanisms of
iTBS, to induce longer carry-over effects, and to establish
the benefits in clinical settings.
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